Morning Briefing
Summaries of health policy coverage from major news organizations
Research Roundup: The Latest Science, Discoveries, And Breakthroughs
A new UCLA study published in Science Advances describes a previously unrecognized way the SARS-CoV-2 nucleocapsid protein can push the immune system into dangerous overdrive. (8/5)
Women with vaginosis are around three times as likely to also test positive for gonorrhea, chlamydia or other bacterial sexually transmitted infections, a new study says. (Thompson, 8/4)
A higher body fat percentage is linked to lower sperm counts and changes in the balance of testosterone and other male hormones, researchers reported July 29 in the journal Human Reproduction. (Thompson, 8/4)
Bone growth among transgender and gender-diverse adolescents slowed compared with peers during pubertal suppression, but partially recovered after starting gender-affirming hormone therapy, a systematic review and meta-analysis showed. (Monaco, 8/3)
Novo Nordisk said Friday that its investigational anti-inflammatory drug did not reduce the risk of major heart events in a pivotal trial, raising questions about the increasingly popular approach of targeting inflammation to prevent cardiovascular complications. (Chen, 7/31)
Men who used the PDE5 inhibitor tadalafil (Cialis) for lower urinary tract symptoms had an increased likelihood of developing glaucoma-related clinical events, according to a large retrospective study. (Bankhead, 8/5)
Patients with inflammatory bowel disease were at increased risk for several psychiatric disorders both before and after diagnosis, according to results from a Swedish cohort study. (Bassett, 8/5)
In an early-stage clinical trial, six participants with peanut allergy showed improved tolerance to small peanut exposures up to four months after they received fecal microbiome transplant using stool capsules. (Chan, 8/5)